| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |